Synonyms: MK-7655 | MK-7655A | MK7655
relebactam is an approved drug (FDA (2019), EMA (2020))
Compound class:
Synthetic organic
Comment: Relebactam is a β-lactamase inhibitor [1].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. FDA (2019) | EMA (2020) |
IUPAC Name ![]() |
[(2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate |
International Nonproprietary Names ![]() |
|
INN number | INN |
10027 | relebactam |
Synonyms ![]() |
MK-7655 | MK-7655A | MK7655 |
Database Links ![]() |
|
Specialist databases | |
Antibiotic DB
![]() |
Relebactam |
Other databases | |
CAS Registry No. | 1174018-99-5 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL3112741 |
DrugBank Ligand | DB12377 |
DrugCentral Ligand | 5342 |
GtoPdb PubChem SID | 405560293 |
PubChem CID | 44129647 |
Search Google for chemical match using the InChIKey | SMOBCLHAZXOKDQ-ZJUUUORDSA-N |
Search Google for chemicals with the same backbone | SMOBCLHAZXOKDQ |
Search PubMed clinical trials | relebactam |
Search PubMed titles | relebactam |
Search PubMed titles/abstracts | relebactam |
UniChem Compound Search for chemical match using the InChIKey | SMOBCLHAZXOKDQ-ZJUUUORDSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | SMOBCLHAZXOKDQ-ZJUUUORDSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Relebactam (links to external site)
Cat. No. HY-16752 |